These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12081336)

  • 1. Hospital prevalence of pulmonary tuberculosis and co-infection with human immunodeficiency virus in Ilorin: a review of nine years (1991-1999).
    Salami AK; Oluboyo PO
    West Afr J Med; 2002; 21(1):24-7. PubMed ID: 12081336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of presentation of tuberculosis and the hospital prevalence of tuberculosis and HIVco-infection in University College Hospital, Ibadan: a review of five years (1998 - 2002).
    Ige OM; Sogaolu OM; Ogunlade OA
    Afr J Med Med Sci; 2005 Dec; 34(4):329-33. PubMed ID: 16752660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria.
    Awoyemi OB; Ige OM; Onadeko BO
    Afr J Med Med Sci; 2002 Dec; 31(4):329-32. PubMed ID: 15027773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection among patients with pulmonary tuberculosis in Nigeria.
    Odaibo GN; Gboun MF; Ekanem EE; Gwarzo SN; Saliu I; Egbewunmi SA; Abebe EA; Olaleye DO
    Afr J Med Med Sci; 2006 Dec; 35 Suppl():93-8. PubMed ID: 18050780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus-associated tuberculosis: pattern and trend in the University of Ilorin Teaching Hospital.
    Salami AK; Katibi IA
    Afr J Med Med Sci; 2006 Dec; 35(4):457-60. PubMed ID: 17722813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pattern of human immunodeficiency virus infection (HIV) in pulmonary tuberculosis patients in Jos, Nigeria.
    Anteyi EA; Idoko JA; Ukoli CO; Bello CS
    Afr J Med Med Sci; 1996 Dec; 25(4):317-21. PubMed ID: 9532299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health point prevalence of human immunodeficiency virus and pulmonary tuberculosis among patients in various parts of Delta State, Nigeria.
    Jemikalajah JD; Okogun GA
    Saudi Med J; 2009 Mar; 30(3):387-91. PubMed ID: 19271068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of HIV seroprevalence in patients with pulmonary tuberculosis in 1999 in Chad].
    Tosi CH; Ngangro MN; Djimadoum N; Richard V
    Med Trop (Mars); 2002; 62(6):627-33. PubMed ID: 12731312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sero-prevalence of HIV antibodies in tuberculosis patients in Ile-Ife, Nigeria.
    Onipede AO; Idigbe O; Ako-Nai AK; Omojola O; Oyelese AO; Aboderin AO; Akinosho ; Komolafe AO; Wemambu SN
    East Afr Med J; 1999 Mar; 76(3):127-32. PubMed ID: 10442110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are smear-positive pulmonary tuberculosis patients a 'sentinel' population for the HIV epidemic in Cameroon?
    Noeske J; Kuaban C; Cunin P
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):346-51. PubMed ID: 15139474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of routine diagnosis of pulmonary tuberculosis in an area of high HIV prevalence.
    Apers L; Wijarajah C; Mutsvangwa J; Chigara N; Mason P; van der Stuyft P
    Int J Tuberc Lung Dis; 2004 Aug; 8(8):945-51. PubMed ID: 15305475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current views on epidemiology of renal tuberculosis.
    Chijioke A
    West Afr J Med; 2001; 20(4):217-9. PubMed ID: 11885875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manifestations and outcome of extra-pulmonary tuberculosis: impact of human immunodeficiency virus co-infection.
    Kwara A; Roahen-Harrison S; Prystowsky E; Kissinger mR; Adams R; Mathison J; Hyslop NE
    Int J Tuberc Lung Dis; 2005 May; 9(5):485-93. PubMed ID: 15875918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV seroprevalence in emergency department patients: Lagos University Teaching Hospital, Lagos, 1999.
    Esan OA; Akanmu AS; Akinsete I
    Niger Postgrad Med J; 2003 Jun; 10(2):71-5. PubMed ID: 14567038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
    Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance and HIV co-infection among pulmonary tuberculosis patients in Haiphong City, Vietnam.
    Khuê PM; Phuc TQ; Hung NV; Jarlier V; Robert J
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):763-8. PubMed ID: 18544201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary tuberculosis among patients visiting a voluntary confidential counseling and testing center, Cambodia.
    Chheng P; Tamhane A; Natpratan C; Tan V; Lay V; Sar B; Kimerling ME
    Int J Tuberc Lung Dis; 2008 Mar; 12(3 Suppl 1):54-62. PubMed ID: 18302824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa.
    Jeena PM; Pillay P; Pillay T; Coovadia HM
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):672-8. PubMed ID: 12150478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of malaria as co-infection in HIV-infected individuals in a malaria endemic area of southeastern Nigeria.
    Onyenekwe CC; Ukibe N; Meludu SC; Ilika A; Aboh N; Ofiaeli N; Ezaeni M; Onochie A
    J Vector Borne Dis; 2007 Dec; 44(4):250-4. PubMed ID: 18092531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human immunodeficiency virus infection in children with tuberculosis.
    Shahab T; Zoha MS; Malik MA; Malik A; Afzal K
    Indian Pediatr; 2004 Jun; 41(6):595-9. PubMed ID: 15235166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.